{"doi":"10.1002/cncr.32802","title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","abstract":"<jats:sec>\n                    <jats:title>Background</jats:title>\n                    <jats:p>The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States.</jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods</jats:title>\n                    <jats:p>Data on new cancer diagnoses during 2001 through 2016 were obtained from the Centers for Disease Control and Prevention‐funded and National Cancer Institute‐funded population‐based cancer registry programs and compiled by the North American Association of Central Cancer Registries. Data on cancer deaths during 2001 through 2017 were obtained from the National Center for Health Statistics' National Vital Statistics System. Trends in incidence and death rates for all cancers combined and for the leading cancer types by sex, racial/ethnic group, and age were estimated by joinpoint analysis and characterized by the average annual percent change during the most recent 5 years (2012‐2016 for incidence and 2013‐2017 for mortality).</jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Results</jats:title>\n                    <jats:p>Overall, cancer incidence rates decreased 0.6% on average per year during 2012 through 2016, but trends differed by sex, racial/ethnic group, and cancer type. Among males, cancer incidence rates were stable overall and among non‐Hispanic white males but decreased in other racial/ethnic groups; rates increased for 5 of the 17 most common cancers, were stable for 7 cancers (including prostate), and decreased for 5 cancers (including lung and bronchus [lung] and colorectal). Among females, cancer incidence rates increased during 2012 to 2016 in all racial/ethnic groups, increasing on average 0.2% per year; rates increased for 8 of the 18 most common cancers (including breast), were stable for 6 cancers (including colorectal), and decreased for 4 cancers (including lung). Overall, cancer death rates decreased 1.5% on average per year during 2013 to 2017, decreasing 1.8% per year among males and 1.4% per year among females. During 2013 to 2017, cancer death rates decreased for all cancers combined among both males and females in each racial/ethnic group, for 11 of the 19 most common cancers among males (including lung and colorectal), and for 14 of the 20 most common cancers among females (including lung, colorectal, and breast). The largest declines in death rates were observed for melanoma of the skin (decreasing 6.1% per year among males and 6.3% among females) and lung (decreasing 4.8% per year among males and 3.7% among females). Among children younger than 15 years, cancer incidence rates increased an average of 0.8% per year during 2012 to 2016, and cancer death rates decreased an average of 1.4% per year during 2013 to 2017. Among adolescents and young adults aged 15 to 39 years, cancer incidence rates increased an average of 0.9% per year during 2012 to 2016, and cancer death rates decreased an average of 1.0% per year during 2013 to 2017.</jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions</jats:title>\n                    <jats:p>Although overall cancer death rates continue to decline, incidence rates are leveling off among males and are increasing slightly among females. These trends reflect population changes in cancer risk factors, screening test use, diagnostic practices, and treatment advances. Many cancers can be prevented or treated effectively if they are found early. Population‐based cancer incidence and mortality data can be used to inform efforts to decrease the cancer burden in the United States and regularly monitor progress toward goals.</jats:p>\n                  </jats:sec>","journal":"Cancer","year":2020,"id":47268,"datarank":7.2624589799510595,"base_score":6.805722553416985,"endowment":6.805722553416985,"self_citation_contribution":1.020858383012548,"citation_network_contribution":6.241600596938511,"self_endowment_contribution":1.020858383012548,"citer_contribution":6.241600596938511,"corpus_percentile":97.57097547768237,"corpus_rank":315,"citation_count":902,"citer_count":100,"citers_with_citation_signal":100,"citers_with_endowment":100,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":0.6031,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":18963,"name":"Elizabeth Ward","orcid":"0000-0002-3575-6639","position":1,"is_corresponding":false},{"id":218365,"name":"Susan Scott","orcid":"0000-0001-5881-8313","position":2,"is_corresponding":false},{"id":98529,"name":"Jiemin Ma","orcid":null,"position":3,"is_corresponding":false},{"id":218367,"name":"Robert N. Anderson","orcid":"0000-0002-2944-6028","position":4,"is_corresponding":false},{"id":218368,"name":"Albert U. Firth","orcid":"0000-0002-6797-0613","position":5,"is_corresponding":false},{"id":218369,"name":"Cheryll C. Thomas","orcid":null,"position":6,"is_corresponding":false},{"id":23097,"name":"Farhad Islami","orcid":"0000-0002-7357-5994","position":7,"is_corresponding":false},{"id":218370,"name":"Hannah K. Weir","orcid":"0000-0001-6568-9708","position":8,"is_corresponding":false},{"id":218371,"name":"Denise Riedel Lewis","orcid":"0000-0003-3385-2958","position":9,"is_corresponding":false},{"id":218372,"name":"Recinda Sherman","orcid":"0000-0003-0530-1075","position":10,"is_corresponding":false},{"id":218373,"name":"Manxia Wu","orcid":null,"position":11,"is_corresponding":false},{"id":218374,"name":"Vicki B. Benard","orcid":"0000-0003-1989-0819","position":12,"is_corresponding":false},{"id":218375,"name":"Lisa C. Richardson","orcid":"0000-0002-9555-7674","position":13,"is_corresponding":false},{"id":11219,"name":"Ahmedin Jemal","orcid":"0000-0002-0000-4111","position":14,"is_corresponding":false},{"id":218028,"name":"Kathleen A. Cronin","orcid":"0000-0002-7282-9323","position":15,"is_corresponding":false},{"id":218376,"name":"Betsy Kohler","orcid":"0000-0002-4020-0328","position":16,"is_corresponding":false},{"id":218362,"name":"S. Jane Henley","orcid":"0000-0002-2420-306X","position":0,"is_corresponding":true}],"reference_count":55,"raw_metadata":null,"created_at":"2026-07-18T14:18:31.320809Z","pmid":"32162336","pmcid":"PMC7299151","fwci":50.3845,"citation_percentile":0.9990412,"influential_citations":7,"oa_status":"bronze","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.25034517.v1","title":"Additional file 2 of Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13532561.v1","title":"Additional file 1 of Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13532561","title":"Additional file 1 of Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.15001290.v1","title":"Additional file 1 of A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.15001290","title":"Additional file 1 of A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22616194.v1","title":"Additional file 1 of Association between human blood metabolome and the risk of breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22616194","title":"Additional file 1 of Association between human blood metabolome and the risk of breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.23647556.v1","title":"Additional file 1 of Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.23647556","title":"Additional file 1 of Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25034442.v1","title":"Additional file 1 of Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25034442","title":"Additional file 1 of Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25034517","title":"Additional file 2 of Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25284799.v1","title":"Additional file 1 of Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25284799","title":"Additional file 1 of Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26552263.v1","title":"Additional file 2 of PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26552263","title":"Additional file 2 of PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26607766.v1","title":"Additional file 1 of Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26607766","title":"Additional file 1 of Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664343.v1","title":"Additional file 2 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664343","title":"Additional file 2 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664349.v1","title":"Additional file 3 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664349","title":"Additional file 3 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664352.v1","title":"Additional file 4 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664352","title":"Additional file 4 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26664355.v1","title":"Additional file 5 of Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"}],"topics":[{"topic_type":"field_of_study","value":"Global Cancer Incidence and Screening","extra":null},{"topic_type":"field_of_study","value":"Colorectal Cancer Screening and Detection","extra":null},{"topic_type":"field_of_study","value":"Economic and Financial Impacts of Cancer","extra":null},{"topic_type":"field_of_study","value":"Medicine","extra":null},{"topic_type":"field_of_study","value":"American Cancer Society","extra":null},{"topic_type":"field_of_study","value":"Centers for Disease Control and Prevention, U.S.","extra":null},{"topic_type":"field_of_study","value":"Cross-Sectional Studies","extra":null},{"topic_type":"field_of_study","value":"Female","extra":null},{"topic_type":"field_of_study","value":"Humans","extra":null},{"topic_type":"field_of_study","value":"Incidence","extra":null},{"topic_type":"field_of_study","value":"Male","extra":null},{"topic_type":"field_of_study","value":"Mortality","extra":null},{"topic_type":"field_of_study","value":"National Cancer Institute (U.S.)","extra":null},{"topic_type":"field_of_study","value":"Neoplasms","extra":null},{"topic_type":"field_of_study","value":"Registries","extra":null},{"topic_type":"field_of_study","value":"Sex Characteristics","extra":null},{"topic_type":"field_of_study","value":"United States","extra":null},{"topic_type":"mesh_term","value":"American Cancer Society","extra":null},{"topic_type":"mesh_term","value":"Centers for Disease Control and Prevention, U.S.","extra":null},{"topic_type":"mesh_term","value":"Cross-Sectional Studies","extra":null},{"topic_type":"mesh_term","value":"Female","extra":null},{"topic_type":"mesh_term","value":"Humans","extra":null},{"topic_type":"mesh_term","value":"Incidence","extra":null},{"topic_type":"mesh_term","value":"Male","extra":null},{"topic_type":"mesh_term","value":"Mortality","extra":null},{"topic_type":"mesh_term","value":"National Cancer Institute (U.S.)","extra":null},{"topic_type":"mesh_term","value":"Neoplasms","extra":null},{"topic_type":"mesh_term","value":"Registries","extra":null},{"topic_type":"mesh_term","value":"Sex Characteristics","extra":null},{"topic_type":"mesh_term","value":"United States","extra":null},{"topic_type":"keyword","value":"Medicine","extra":null},{"topic_type":"keyword","value":"Cancer","extra":null},{"topic_type":"keyword","value":"Demography","extra":null},{"topic_type":"keyword","value":"Cancer registry","extra":null},{"topic_type":"keyword","value":"Incidence (geometry)","extra":null},{"topic_type":"keyword","value":"Lung cancer","extra":null},{"topic_type":"keyword","value":"Population","extra":null},{"topic_type":"keyword","value":"Ethnic group","extra":null},{"topic_type":"keyword","value":"Colorectal cancer","extra":null},{"topic_type":"keyword","value":"Prostate cancer","extra":null},{"topic_type":"keyword","value":"Cancer prevention","extra":null},{"topic_type":"keyword","value":"Mortality rate","extra":null},{"topic_type":"keyword","value":"Disease","extra":null},{"topic_type":"keyword","value":"Gerontology","extra":null},{"topic_type":"keyword","value":"Internal medicine","extra":null},{"topic_type":"keyword","value":"Environmental health","extra":null},{"topic_type":"keyword","value":"Annual Report to the Nation","extra":null},{"topic_type":"keyword","value":"Epidemiology","extra":null},{"topic_type":"keyword","value":"National Program of Cancer Registries (NPCR)","extra":null},{"topic_type":"keyword","value":"National Vital Statistics System (NVSS)","extra":null},{"topic_type":"keyword","value":"North American Association of Central Cancer Registries (NAACCR)","extra":null},{"topic_type":"keyword","value":"Surveillance","extra":null},{"topic_type":"keyword","value":"and End Results (SEER) program","extra":null},{"topic_type":"keyword","value":"incidence","extra":null},{"topic_type":"keyword","value":"mortality","extra":null},{"topic_type":"keyword","value":"trends","extra":null},{"topic_type":"sdg","value":"Good health and well-being","extra":"0"}]}